Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Adverum Biotechnlgs (ADVM)
Adverum Biotechnlgs (ADVM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 121,696
  • Shares Outstanding, K 100,575
  • Annual Sales, $ 0 K
  • Annual Income, $ -154,540 K
  • 60-Month Beta 0.72
  • Price/Sales 33.50
  • Price/Cash Flow N/A
  • Price/Book 0.73
Trade ADVM with:

Options Overview Details

View History
  • Implied Volatility 174.29% ( -80.51%)
  • Historical Volatility 86.21%
  • IV Percentile 28%
  • IV Rank 8.44%
  • IV High 1,185.11% on 06/10/22
  • IV Low 81.14% on 07/08/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 74
  • Volume Avg (30-Day) 76
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 8,738
  • Open Int (30-Day) 8,330

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate -0.32
  • Number of Estimates 2
  • High Estimate -0.31
  • Low Estimate -0.33
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +27.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7430 +62.85%
on 05/19/23
1.2400 -2.42%
on 06/01/23
+0.4600 (+61.33%)
since 05/02/23
3-Month
0.6810 +77.68%
on 04/10/23
1.2400 -2.42%
on 06/01/23
+0.4670 (+62.85%)
since 03/02/23
52-Week
0.5310 +127.87%
on 12/27/22
1.8200 -33.52%
on 07/14/22
+0.2884 (+31.29%)
since 06/02/22

Most Recent Stories

More News
Adverum Biotechnologies: Q1 Earnings Snapshot

Adverum Biotechnologies: Q1 Earnings Snapshot

ADVM : 1.2100 (+6.14%)
Is Adial Pharmaceuticals (ADIL) Stock Outpacing Its Medical Peers This Year?

Here is how Adial Pharmaceuticals, Inc. (ADIL) and Adverum Biotechnologies (ADVM) have performed compared to their sector so far this year.

ADIL : 0.2780 (+3.89%)
ADVM : 1.2100 (+6.14%)
Rumble, Braze rise; Virgin Orbit, Sientra fall

Stocks that traded heavily or had substantial price changes Friday: Rumble, Braze rise; Virgin Orbit, Sientra fall

ADVM : 1.2100 (+6.14%)
SIEN : 1.6300 (-0.61%)
BB.TO : 7.15 (-1.24%)
NKLA : 0.5855 (+1.97%)
Adverum Biotechnologies: Q4 Earnings Snapshot

Adverum Biotechnologies: Q4 Earnings Snapshot

ADVM : 1.2100 (+6.14%)
Adverum Biotechnologies: Q3 Earnings Snapshot

Adverum Biotechnologies: Q3 Earnings Snapshot

ADVM : 1.2100 (+6.14%)
Adverum (ADVM) Doses First Patient in the Mid-Stage wAMD Study

Adverum (ADVM) initiates dosing in the phase II LUNA study, currently investigating its lead product candidate ixoberogene soroparvovec for wet age-related macular degeneration.

REGN : 739.95 (+1.20%)
DVAX : 11.66 (+1.57%)
BAYRY : 14.0900 (+0.79%)
ADVM : 1.2100 (+6.14%)
Adverum Biotechnologies to Participate in the 2nd Annual H.C. Wainwright Ophthalmology Virtual Conference

REDWOOD CITY, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish...

ADVM : 1.2100 (+6.14%)
Adverum Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company that aims to establish...

ADVM : 1.2100 (+6.14%)
Adverum Biotechnologies Presents Best-Corrected Visual Acuity and Central Subfield Thickness Analyses After a Single IVT Injection of ADVM-022 (Ixo-vec) in the OPTIC Study in Wet AMD

- Study participants had an 81%-98% reduction in annualized anti-VEGF injections and demonstrated continuous aflibercept expression levels through three...

ADVM : 1.2100 (+6.14%)
Adverum Biotechnologies Announces Upcoming Data Presentation at ASRS 2022

- Adverum to present new best-corrected visual acuity (BCVA) data from the OPTIC Trial of ADVM-022 (ixoberogene soroparvovec) in wet AMD REDWOOD...

ADVM : 1.2100 (+6.14%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Adverum is a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases. Adverum develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum's core capabilities include clinical development,...

See More

Key Turning Points

3rd Resistance Point 1.3367
2nd Resistance Point 1.2833
1st Resistance Point 1.2467
Last Price 1.2100
1st Support Level 1.1567
2nd Support Level 1.1033
3rd Support Level 1.0667

See More

52-Week High 1.8200
Fibonacci 61.8% 1.3276
Last Price 1.2100
Fibonacci 50% 1.1755
Fibonacci 38.2% 1.0234
52-Week Low 0.5310

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar